siRNA therapy decreases triglycerides in patients with uncommon ailment

.RESEARCH HIGHLIGHT.19 September 2024.

Plozasiran reduced triglyceride levels through 80% and also lowered the danger of pancreatitis in patients along with persistent chylomicronemia, along with or without a hereditary prognosis.

Articles You Can Be Interested In

• Career Advice
• E-commerce
• Online Marketing
• Entrepreneurship
• Weddings
• Weddings
• Tech Updates
• Local News
• Data Science
• Business
• Cybersecurity
• PR & Branding
• Retirement
• Charity
• E-commerce
• Cultural Events
• Web Development
• Weddings
• Public Policy
• Entrepreneurship